22 September 2022
Alex Grassino, Head of Macro Strategy, North America
The US Federal Reserve’s (Fed’s) decision on 21 September to raise US interest rates by 75 basis points (bps) to 3% - 3.25% was well priced into the markets and, therefore, should come as little surprise to investors. The accompanying statement also contained little new information. Why did the markets react so strongly?
The devil, as the saying goes, is very much in the details. In this instance, we’re referring to the underlying message from the Fed. The announcement was accompanied by the FOMC’s latest economic projections, which included its closely watched Federal funds rate projections (the dot plot). It’s fair to say that the latest projections and Fed Chair Jerome Powell’s post-meeting press conference cemented an increasingly negative outlook.
Fed officials have turned more hawkish since June
FOMC projections |
Projected interest rate—median (%) |
||
2022 |
2023 |
2024 |
|
June |
3.4 |
3.8 |
3.4 |
September |
4.4 |
4.6 |
3.9 |
Source: US Federal Reserve, 21 September, 2022. FOMC refers to the Federal Open Market Committee.
We think two factors contributed to the Fed’s increasingly hawkish tone: First, although the employment picture had shown signs of softening earlier in the summer, recent data suggested that the labour market has strengthened since then. Second—and more important, in our view—was August’s outsized 0.6% (on a month-over-month basis) increase in core CPI.
Prior to the release of August’s CPI data, we had envisioned a more modest path that would have seen policy rates peak at 3.5%, with the final hike for this cycle arriving just before year end. Now, we expect Federal funds rate to hit 4.25% in early 2023; with the possibility of an additional 25bps added to the peak rate should forthcoming inflation data remain stubbornly strong. Should that happen, our forecast will mirror the Fed’s own projections. In other words, we’re now in data-dependent territory.
The way we see it, inflationary pressure will have to come back down to a more manageable pace (e.g., staying in the 0.2% to 0.3% range for a several months) before the Fed begins to consider pausing rate hikes. Put differently, there probably isn’t enough time between now and the next Fed meeting for inflation data to weaken sufficiently to reasonably justify a modest 25bps rate-hike in November—meaning that once again, the next hike is highly likely to be material. That said, the Fed could potentially provide the markets with a festive surprise in December and signal a willingness to slow the pace of hikes should upcoming economic data unfold in the right way (i.e., weaken significantly). That’s about as optimistic as we’d get.
We do, however, have higher conviction that the Fed will begin easing before the end of 2023 for two reasons:
Fed’s first rate cut of 2025: Implications & takeaways
After nine months on pause, the US Federal Reserve (Fed) announced another rate cut of 25 basis points (bps) on 17 September (US time), bringing the federal funds rate into a target range of 4%-4.25%. Alex Grassino, Global Chief Economist, and Yuting Shao, Senior Global Macro Strategist, share their latest views on the rate decision and its implications for Asia.
Global Healthcare Equities Q&A
This Q&A provides an updated overview of sector performance, examines the impact of recent US healthcare policy developments, and outlines key investment strategies and themes. It also highlights the growing role of artificial intelligence (AI) in healthcare innovation and shares practical tips to help investors navigate market volatility.
The Impact of US Tariffs on Indian Exports
As Indian exports to the US face escalating tariffs, we examine the potential impact of these measures, placing them in the context of broader trade dynamics, sector-specific exposure, and macroeconomic implications.
Fed’s first rate cut of 2025: Implications & takeaways
After nine months on pause, the US Federal Reserve (Fed) announced another rate cut of 25 basis points (bps) on 17 September (US time), bringing the federal funds rate into a target range of 4%-4.25%. Alex Grassino, Global Chief Economist, and Yuting Shao, Senior Global Macro Strategist, share their latest views on the rate decision and its implications for Asia.
The Impact of US Tariffs on Indian Exports
As Indian exports to the US face escalating tariffs, we examine the potential impact of these measures, placing them in the context of broader trade dynamics, sector-specific exposure, and macroeconomic implications.
Global Healthcare Equities Q&A
This Q&A provides an updated overview of sector performance, examines the impact of recent US healthcare policy developments, and outlines key investment strategies and themes. It also highlights the growing role of artificial intelligence (AI) in healthcare innovation and shares practical tips to help investors navigate market volatility.
©1999 - 2025 Manulife Investment Management (M) Berhad (Registration No. 200801033087 (834424-U))
